Cargando…

Fenfluramine in the treatment of hypertensive patients with refractory obesity.

Detalles Bibliográficos
Autores principales:	Scott, M. E., Nelson, P. G.
Formato:	Texto
Lenguaje:	English
Publicado:	Ulster Medical Society 1975
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2385486/ https://www.ncbi.nlm.nih.gov/pubmed/1124562

Ejemplares similares

Fenfluramine in the successful treatment of super-refractory status epilepticus in a patient with Dravet syndrome
por: Millett, David, et al.
Publicado: (2021)

A review of fenfluramine for the treatment of Dravet syndrome patients
por: Simon, Kayla, et al.
Publicado: (2021)

Fenfluramine: New Treatment for Seizures in Dravet Syndrome
por: Pierce, Joanna Garcia, et al.
Publicado: (2020)

Fenfluramine: a plethora of mechanisms?
por: Sourbron, Jo, et al.
Publicado: (2023)

Risk of valvular heart disease associated with use of fenfluramine
por: Hopkins, Paul N, et al.
Publicado: (2003)

Improving Therapy of Pharmacoresistant Epilepsies: The Role of Fenfluramine
por: Dini, Gianluca, et al.
Publicado: (2022)

Fenfluramine: A Review in Dravet and Lennox-Gastaut Syndromes
por: Frampton, James E.
Publicado: (2023)

In vitro evaluation of fenfluramine and norfenfluramine as victims of drug interactions
por: Martin, Parthena, et al.
Publicado: (2022)

Corrigendum: Improving therapy of pharmacoresistant epilepsies: The role of fenfluramine
por: Dini, Gianluca, et al.
Publicado: (2023)

Correction to: Fenfluramine: A Review in Dravet and Lennox-Gastaut Syndromes
por: Frampton, James E.
Publicado: (2023)

Valvular regurgitation and surgery associated with fenfluramine use: an analysis of 5743 individuals
por: Dahl, Charles F, et al.
Publicado: (2008)

Reintroducing Fenfluramine as a Treatment for Seizures: Current Knowledge, Recommendations and Gaps in Understanding
por: Dini, Gianluca, et al.
Publicado: (2023)

Effect of fenfluramine on convulsive seizures in CDKL5 deficiency disorder
por: Devinsky, Orrin, et al.
Publicado: (2021)

Fenfluramine: A Review of Pharmacology, Clinical Efficacy, and Safety in Epilepsy
por: Samanta, Debopam
Publicado: (2022)

Efficacy and Safety of Fenfluramine in Epilepsy: A Systematic Review and Meta-analysis
por: Tabaee Damavandi, Payam, et al.
Publicado: (2023)

An examination of the efficacy and safety of fenfluramine in adults, children, and adolescents with Dravet syndrome in a real‐world practice setting: A report from the Fenfluramine European Early Access Program
por: Guerrini, Renzo, et al.
Publicado: (2022)

Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome: A Randomized Clinical Trial
por: Knupp, Kelly G., et al.
Publicado: (2022)

Fenfluramine-induced gene dysregulation in human pulmonary artery smooth muscle and endothelial cells
por: Yao, Weijuan, et al.
Publicado: (2011)

In vitro evaluation suggests fenfluramine and norfenfluramine are unlikely to act as perpetrators of drug interactions
por: Martin, Parthena, et al.
Publicado: (2022)

The anorexic effect of DL-fenfluramine is dependent on animals' habituation to different food types
por: Yi, Sun Shin, et al.
Publicado: (2022)

Cardiovascular safety of fenfluramine in the treatment of Dravet syndrome: Analysis of an ongoing long‐term open‐label safety extension study
por: Lai, Wyman W., et al.
Publicado: (2020)

Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens: A Randomized Clinical Trial
por: Nabbout, Rima, et al.
Publicado: (2020)

Pharmacological Analysis of the Anti-epileptic Mechanisms of Fenfluramine in scn1a Mutant Zebrafish
por: Sourbron, Jo, et al.
Publicado: (2017)

Efficacy of Fenfluramine and Norfenfluramine Enantiomers and Various Antiepileptic Drugs in a Zebrafish Model of Dravet Syndrome
por: Li, Jing, et al.
Publicado: (2021)

Effect of fenfluramine on seizures and comorbidities in SCN8A‐developmental and epileptic encephalopathy: A case series
por: Aledo‐Serrano, Ángel, et al.
Publicado: (2022)

Pharmacological Characterization of an Antisense Knockdown Zebrafish Model of Dravet Syndrome: Inhibition of Epileptic Seizures by the Serotonin Agonist Fenfluramine
por: Zhang, Yifan, et al.
Publicado: (2015)

Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox–Gastaut syndrome: Interim analysis of an open‐label extension study
por: Knupp, Kelly G., et al.
Publicado: (2022)

Fenfluramine for Treating Dravet Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
por: Wijnen, Ben, et al.
Publicado: (2022)

Low‐dose fenfluramine significantly reduces seizure frequency in Dravet syndrome: a prospective study of a new cohort of patients
por: Schoonjans, A., et al.
Publicado: (2016)

Fenfluramine Reduces [(11)C]Cimbi-36 Binding to the 5-HT(2A) Receptor in the Nonhuman Primate Brain
por: Yang, Kai-Chun, et al.
Publicado: (2017)

Fenfluramine significantly reduces day‐to‐day seizure burden by increasing number of seizure‐free days and time between seizures in patients with Dravet syndrome: A time‐to‐event analysis
por: Sullivan, Joseph, et al.
Publicado: (2021)

Fenfluramine HCl (Fintepla(®)) provides long‐term clinically meaningful reduction in seizure frequency: Analysis of an ongoing open‐label extension study
por: Sullivan, Joseph, et al.
Publicado: (2020)

Effects of low-doses of methamphetamine on d-fenfluramine-induced head-twitch response (HTR) in mice during ageing and c-fos expression in the prefrontal cortex
por: Sun, Yina, et al.
Publicado: (2023)

Fenfluramine diminishes NMDA receptor-mediated seizures via its mixed activity at serotonin 5HT2A and type 1 sigma receptors
por: Rodríguez-Muñoz, María, et al.
Publicado: (2018)

An Update on Refractory Hypertension
por: Matanes, Faris, et al.
Publicado: (2022)

Effects of developmental exposure to manganese and/or low iron diet: Changes to metal transporters, sucrose preference, elevated zero-maze, open-field, and locomotion in response to fenfluramine, amphetamine, and MK-801
por: Amos-Kroohs, Robyn M., et al.
Publicado: (2015)

Identifying treatment response to antihypertensives in patients with obesity-related hypertension
por: Schrover, Ilse M., et al.
Publicado: (2017)

Prevalence and Clinical Characteristics of Refractory Hypertension
por: Armario, Pedro, et al.
Publicado: (2017)

Refractory and Resistant Hypertension: Antihypertensive Treatment Failure versus Treatment Resistance
por: Calhoun, David A.
Publicado: (2016)

Therapy refractory hypertension in adults: aortic coarctation has to be ruled out
por: Hemels, M. E. W., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_84d6bj36pjl0uq8u18lnf8re1e